The original 2015 Cell Metabolism study demonstrated that intraperitoneal MOTS-c injections (5 mg/kg) in mice fed a high-fat diet prevented obesity and insulin resistance, with effects on fat mass, fasting glucose, and insulin sensitivity that rivaled pharmaceutical intervention [1]
GLOW Blend Research Applications How GHK-Cu, BPC-157 and TB-500 interact at fibroblast signaling and extracellular-matrix deposition in vitro
These treatments can help support healthy weight goals when combined with nutrition, exercise, and ongoing medical monitoring
Given the critical importance of stability and bioavailability for peptide research utility, we strongly recommend using BPC 157 in its optimal lyophilised form for research purposes
In contrast, a B12 injection (typically administered into a muscle, known as an intramuscular injection) bypasses the entire digestive system